Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CareRA2020 / CareRA2020 LTE in early rheumatoid arthritis
2023-510189-28-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of etanercept, leflunomide and methotrexate in rheumatoid arthritis (RA) (3 arms), sponsored by UZ Leuven. Started Feb 2024; status: completed.
02
Drugs
etanerceptleflunomidemethotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2023-510189-28-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510189-28-00.